Peanut allergy food challenge biomarker study
Part of Immune system & allergy clinical trials.
This study aims to identify markers in the blood that could help predict how severe a peanut allergy reaction might be. If you qualify, your child will undergo a supervised peanut challenge to see how their body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 17 years old.
- Your child must be allergic to peanuts, confirmed by a test or a past reaction.
- Your child must be avoiding peanuts currently.
- Your child cannot have had life-threatening anaphylaxis to peanuts (like needing a breathing tube).
- Your child cannot be pregnant (if applicable).
- Your child must not have received certain allergy treatments like Xolair or Dupixent in the past 1-2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding tezepelumab (a biologic drug) to peanut oral immunotherapy can help people with peanut allergy better tolerate small amounts of peanut protein without having an allergic reaction.
This study tests whether a treatment program can help children and teenagers with peanut allergies develop tolerance to peanuts over time. The goal is to reduce the risk of serious allergic reactions if they accidentally eat peanuts.
This study looks at which early test results and symptoms help predict whether a child will still have a peanut allergy by age 5. It may help families and doctors better understand who is at higher risk and plan next steps.
This study is observing children with food allergies who are willing to do an oral food challenge (eating the allergen in a safe clinic setting). It helps doctors learn more about how allergies affect children.
This study looks for blood test patterns that may predict whether a child with eczema (atopic dermatitis) is likely to have a food allergy. If you join, you may do supervised oral food challenges with a placebo and the suspected foods to see what triggers symptoms.
This trial tests an investigational medication called LP-003 to see if it can reduce allergic reactions to peanuts. It may help people who are allergic to peanuts be able to tolerate small amounts.
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.